Evidence map›Paper›PMID 33126601›Full record

ArticleJournal of clinical medicine2020

Evaluating the Association between Contrast Medium Dosage and Acute Kidney Injury in Transcatheter Aortic Valve Replacement Using Different Predictive Models.

Markus Mach, Waseem Hasan, Martin Andreas, Bernhard Winkler, Gabriel Weiss, Christopher Adlbrecht, Georg Delle-Karth, Martin Grabenwöger

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Markus MachDepartment of Cardiac Surgery, Medical University of Vienna, 1090 Vienna, Austria.ORCID 0000-0002-3184-4914
Waseem HasanFaculty of Medicine, Imperial College London, London SW7 2AZ, UK.
Martin AndreasDepartment of Cardiac Surgery, Medical University of Vienna, 1090 Vienna, Austria.
Bernhard WinklerHeart Team Vienna, Department of Cardio-Vascular Surgery, Vienna North Hospital-Clinic Floridsdorf and the Karl Landsteiner Institute for Cardio-Vascular Research, 1130 Vienna, Austria.
Gabriel WeissHeart Team Vienna, Department of Cardio-Vascular Surgery, Vienna North Hospital-Clinic Floridsdorf and the Karl Landsteiner Institute for Cardio-Vascular Research, 1130 Vienna, Austria.
Christopher AdlbrechtVienna North Hospital-Clinic Floridsdorf and the Karl Landsteiner Institute for Cardiovascular and Critical Care Research, 1210 Vienna, Austria.
Georg Delle-KarthVienna North Hospital-Clinic Floridsdorf and the Karl Landsteiner Institute for Cardiovascular and Critical Care Research, 1210 Vienna, Austria.
Martin GrabenwögerHeart Team Vienna, Department of Cardio-Vascular Surgery, Vienna North Hospital-Clinic Floridsdorf and the Karl Landsteiner Institute for Cardio-Vascular Research, 1130 Vienna, Austria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent studies have suggested that contrast medium (CM) volume is associated with acute kidney injury (AKI) after transcatheter aortic valve replacement (TAVR). However, in a high-risk elderly TAVR population, the prognostic value and ideal threshold of CM dosage for AKI is unclear. Data of 532 successive TAVR patients (age 81.1 ± 6.8 years, EuroSCORE II 4.8% ± 6.0%) were therefore retrospectively analyzed. Based on a recently published formula, the renal function (preprocedural serum creatinine: SCr) corrected ratio of CM and body weight (CM*SCr/BW) was calculated to determine the risk of postprocedural contrast-associated AKI. AKI occurred in 94 patients (18.3%) and significantly increased 1-year all-cause mortality (23.4% vs. 13.1%;

Indexed as

AKIcontrast mediummortalityrenal functionTAVR

Identifiers

PMID33126601
PMCPMC7692089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.